Keywords: |
signal transduction; unclassified drug; overall survival; sorafenib; drug efficacy; drug safety; liver cell carcinoma; carcinoma, hepatocellular; liver neoplasms; antineoplastic agent; cell proliferation; cell survival; microrna; gene expression; editorial; cancer cell culture; angiogenesis; hypoxia; messenger rna; carcinogenicity; interleukin 6; upregulation; epithelial cell adhesion molecule; micrornas; hypoxia inducible factor 1alpha; hypoxia-inducible factor 1, alpha subunit; pr 104; i kappa b; ezn 2968; microrna 199b
|